ESCRS - Redefining POAG ;
ESCRS - Redefining POAG ;

Redefining POAG

Open-angle glaucoma subtypes: distinct causes requiring specific treatment.

Redefining POAG
Howard Larkin
Howard Larkin
Published: Wednesday, February 1, 2017
To better diagnose and treat patients, primary open-angle glaucoma (POAG) should be redefined in terms of several identifiable subtypes, Louis R Pasquale MD, FARVO, of Harvard Medical School, Boston, USA, told Glaucoma Subspecialty Day at the 2016 American Academy of Ophthalmology Annual Meeting in Chicago, USA. “POAG is a remarkably heterogeneous disease with distinct but overlapping subtypes,” Dr Pasquale said in his American Glaucoma Society Lecture. Each has its own distinct age of onset, intraocular pressure (IOP) profile and structural optic nerve features. Biochemical markers specific to each subtype also point to specific biochemical pathways that may be successfully targeted for treatment. PC-OAG Paracentral OAG, or PC-OAG, in which vision loss is mainly in the paracentral region, is marked by low IOP and difficulty keeping IOP low enough to prevent progression, Dr Pasquale said. 16mmHg is a high number for these patients. PC-OAG appears to be related to nitric oxide (NO) signalling, and patients should be encouraged to eat foods with nitrates such as leafy green vegetables. Medications targeting NO are in development, Dr Pasquale added. AD-OAG African-derived OAG, or AD-OAG, appears in young patients and progresses quickly, sometimes leading to blindness in patients in their third and fourth decades, Dr Pasquale said. AD-OAG is seen mostly in patients of African descent, with one study finding almost 21% of those 20 to 40 years of age with IOP of 24mmHg or higher, or cup-to-disc ratio of 0.7 or more in one eye. AD-OAG should be screened for and treated early. Siblings and children of patients should be screened. ED-OAG Estrogen-derived OAG, or ED-OAG, appears related to lower lifetime exposure to estrogen, with late menarche, oral contraceptive use, early menopause and early oophorectomy risk factors, Dr Pasquale said. Overall, high IOP is not a reliable marker for POAG, with normal IOP observed in up to 90% of glaucoma patients in some populations, Dr Pasquale noted. Pressures of 35 or higher are rare for POAG types, and may indicate steroid exposure or secondary glaucoma. In cases of rapidly progressing glaucoma, diurnal curves should be taken and neuroimaging considered. More study is needed to determine the nature of the various subtypes and treatments for them, but recognising they exist is a good start, Dr Pasquale concluded. “Let’s help our patients by taking the ‘P’ out of POAG.” Louis R Pasquale: louis_pasquale@meei.harvard.edu
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;